Simvastatin increases plasma NO2− and NO3− levels in patients with hypercholesterolemia
- 1 November 1996
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 127 (1) , 43-47
- https://doi.org/10.1016/s0021-9150(96)05933-3
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)The Lancet, 1994
- Beneficial effect of cholesterol-lowering therapy on coronary endothelium-dependent relaxation in hypercholesterolaemic patientsThe Lancet, 1993
- Impaired endothelium-dependent vasodilation of forearm resistance vessels in hypercholesterolaemiaThe Lancet, 1992
- The 1991 Ulf von Euler Lecture:Thel‐arginine: nitric oxide pathwayActa Physiologica Scandinavica, 1992
- Effects of high-density lipoprotein on acetylcholine-induced coronary vasoreactivityThe American Journal of Cardiology, 1991
- Effects of native and oxidized low density lipoproteins on formation and inactivation of endothelium-derived relaxing factor.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta.Journal of Clinical Investigation, 1990
- Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.Journal of Clinical Investigation, 1990
- Leukaemia and radiationNature, 1990
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987